1-9 of 9
Oliver Kriege
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Follow-up of the Randomized ASAP Trial Shows No Survival Advantage for Patients with Poor Responsive or Relapsed AML Who Received Intensive Salvage Chemotherapy for Remission Induction Prior to Allogeneic Transplantation Compared to Immediate Allogeneic Transplantation

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner Drouet, Lutz Peter Hermann Mueller, Christoph Schmid, Stefan W. Krause, Wolfgang Andreas Bethge, Edgar Jost, Uwe Platzbecker, Stefan Klein, Judith Niederland, Martin Kaufmann, Kerstin Schäfer-Eckart, Henning Baldauf, Friedrich Stölzel, Sarah Trost, Christoph Röllig, Malte von Bonin, Katharina Egger-Heidrich, Désirée Kunadt, Björn Steffen, Beate Hauptrock, Christoph Schliemann, Katja Sockel, Fabian Lang, Oliver Kriege, Judith Schaffrath, Christian Reicherts, Wolfgang E. Berdel, Hubert Serve, Gerhard Ehninger, Alexander H. Schmidt, Jan-Henrik Mikesch, Martin Bornhäuser, Johannes Schetelig
Journal: Blood
Blood (2024) 144 (Supplement 1): 776.
https://doi.org/10.1182/blood-2024-204763
Published: 2024
Journal Articles

Implementation of CMV-T-Track® in Clinical Routine to Guide Management of CMV Reactivation

Jonas Wißkirchen, Diana Wolff, Isabelle Ries, Oliver Kriege, Pascal Wölfinger, Beate Hauptrock, Matthias Theobald, Eva-Maria Wagner Drouet
Journal: Blood
Blood (2023) 142 (Supplement 1): 2180.
https://doi.org/10.1182/blood-2023-187382
Published: 2023
Journal Articles

Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena I Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia M. Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Haenel, Charlotte Neuerburg, Vladan Vucinic, Christian Jehn, Julia Severmann, Maxi Wass, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Hermann Krüger, Ulrich Kaiser, Sebastian Scholl, Lea Henning, Guido Kobbe, Rainer Haas, Nael Alakel, Maximilian Alexander Röhnert, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Michael Heuser, Tim Sauer, Katharina S. Goetze, Eva Maria Wagner, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Thomas Schroeder, Moritz Moritz Middeke
Journal: Blood
Blood (2021) 138 (Supplement 1): 33.
https://doi.org/10.1182/blood-2021-153440
Published: 2021
Journal Articles

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

Esther Schuler, MD, Eva-Maria Wagner-Drouet, MD, Salem Ajib, MD, Gesine Bug, Martina Crysandt, MD, Sabine Dressler, MD, Andreas Hausmann, MD, Daniela Heidenreich, MD, Klaus Hirschbühl, MD, Matthias Hoepting, MD, Edgar Jost, MD, Jennifer Kaivers, MD, Stefan A Klein, MD, Lambros Kordelas, MD, Oliver Kriege, MD, Lutz Peter Mueller, MD, Christina Rautenberg, MD, Judith Schaffrath, MD, Christoph Schmid, MD, Daniel Wolff, MD, Martin Bornhaeuser, MD, Thomas Schroeder, MD, Guido Kobbe, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4563.
https://doi.org/10.1182/blood-2019-125087
Published: 2019
Journal Articles

NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML

Daniel Sasca, Jakub Szybinski, Andrea Schüler, Viral Shah, Jan Heidelberger, Patricia S. Haehnel, Anna Dolnik, Oliver Kriege, Eva-Marie Fehr, Wolf H. Gebhardt, George Reid, Claudia Scholl, Matthias Theobald, Lars Bullinger, Petra Beli, Thomas Kindler
Journal: Blood
Blood (2019) 133 (21): 2305–2319.
https://doi.org/10.1182/blood-2018-12-889725
Published: 2019
Includes: Supplemental data
Journal Articles

Ibrutinib Abrogates TREM-1 Mediated Neutrophil Activation

Nicole Stadler, Astrid Hasibeder, Pamela Aranda Lopez, Alexander Desuki, Oliver Kriege, Alexander N.R. Weber, Christian Michel, Daniel Teschner, Georg Hess, MD, Matthias Theobald, MD, Markus Radsak, MD
Journal: Blood
Blood (2016) 128 (22): 3691.
https://doi.org/10.1182/blood.V128.22.3691.3691
Published: 2016
Journal Articles

Idelalisib Impairs TREM-1 and TLR Mediated Neutrophil Activation

Astrid Hasibeder, Nicole Stadler, Pamela Aranda Lopez, Alexander Desuki, Oliver Kriege, Alexander N.R. Weber, Christian Michel, Daniel Teschner, Georg Hess, MD, Matthias Theobald, MD, Markus Radsak, MD
Journal: Blood
Blood (2016) 128 (22): 2510.
https://doi.org/10.1182/blood.V128.22.2510.2510
Published: 2016
Journal Articles

Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia

Daniel Sasca, MD, Andrea Schueler, PhD, Jakub Szybinski, Oliver Kriege, MD, Kerstin Kunz, Eva Marie Fehr, MD, Patricia Haehnel, PhD, Wolf Henning Gebhardt, PhD, Gerge Reid, PhD, Matthias Theobald, MD PhD, Lars Bullinger, MD, Thomas Kindler, MD
Journal: Blood
Blood (2015) 126 (23): 311.
https://doi.org/10.1182/blood.V126.23.311.311
Published: 2015
Journal Articles

SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia

Daniel Sasca, Patricia S. Hähnel, Jakub Szybinski, Kaml Khawaja, Oliver Kriege, Saskia V. Pante, Lars Bullinger, Susanne Strand, Dennis Strand, Matthias Theobald, Thomas Kindler
Journal: Blood
Blood (2014) 124 (1): 121–133.
https://doi.org/10.1182/blood-2013-11-538819
Published: 2014
Includes: Supplemental data